Familial susceptibility to aminoglycoside ototoxicity due to the A1555G mutation in the mitochondrial DNA;Predisposición familiar a la ototoxicidad de los aminoglucósidos debido a la mutación A1555G del ADN mitocondrial

Medicina Clinica

Volumn 121, Issue 6, 2003, Pages 216-218

  Gallo Terán, Jaime ^a   Morales Angulo, Carmelo ^b   del Castillo, Ignacio ^c   Moreno Pelayo, Miguel Ángel ^c   Mazón, Ángel ^a   Moreno, Felipe ^c  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL SIERRALLANA   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

A1555G; Aminoglycosides; Mitochondrial mutations; Nonsyndromic hearing loss; Ototoxicity

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; MITOCHONDRIAL DNA;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FAMILY STUDY; FEMALE; GENE MUTATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENETICS; PERCEPTION DEAFNESS; POLYMERASE CHAIN REACTION; RELATIVE;

EID: 0042064951     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13049917     Document Type: Article

References (10)

1. Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993;4:289-94.
2. Guan MX, Fischel-Ghodsian N, Attardi G. A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum Mol Genet 2000;9:1787-93.
3. Recomendación BIAP (Bureau International d'Audiophonologie) 02/1, Lisboa, 1997. Disponible en: http://www.biap.org
4. Lemkens N, Vermeire K, Brokx JPL, Fransen E, Van Camp G, Van de Heyning PH. Interpretation of pure-tone thresholds in sensorineural hearing loss (SNHL): a review of measurement variability and age-specific references. Acta Otorhinolaryngol Belg 2002;56:341-52.
5. Sarduy M, del Castillo I, Villamar M, Romero L, Herraiz C, Hernández FJ, et al. Genetic study of mitochondrially inherited sensorineural hearing impairment in eight large families from Spain and Cuba. In: Stephens D, Read A, Martini A, editors. Developments in genetic hearing impairment. London: Whurr Publishers, 1998; p. 121-5.
6. Torroni A, Cruciani F, Rengo C, Sellitto D, López-Bigas N, Rabionet R, et al. The A1555G mutation in the 12S rRNA gene of human mtDNA: recurrent origins and founder events in families affected by sensorineural deafness. Am J Hum Genet 1999;65:1349-58.
7. Estivill X, Govea N, Barcelo A, Perello E, Badenas C, Romero E, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am J Hum Genet 1998; 62:27-35.
8. Zhang L, Lu M, Huang Y, Zhou X, Qiu D, Wang W. The relation between mitochondrial DNA mutation and aminoglycoside antibiotics-induced deafness. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 1999;16:138-40.
9. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Ann N Y Acad Sci 1999; 884:99-109.
10. Casano RA, Johnson DF, Bykhovskaya Y, Torricelli F, Bigozzi M, Fischel-Ghodsian N. Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am J Otolaryngol 1999;20:151-6.